Clinical Trial Results Show Zestra® for Women Overcomes Sexual Side Effects of SSRIs
The Journal of Sex and Marital Therapy reported in its current issue positive findings of a
randomized, double blind crossover trial designed to test the efficacy and safety of Zestra® for
Women. The botanical feminine massage oil, formulated to enhance female sexual pleasure and
arousal, is the only non-prescription women’s topical product supported by an FDA quality clinical
trial. Zestra® for Women also meets FDA qualifications and standards for cosmetic personal care
products and massage oils.
Zestra® was well tolerated among all women tested, including those suffering from Female Sexual
Arousal Disorder (FSAD), and those without the condition. All women experienced improved
levels of desire, satisfaction with level of sexual arousal, genital sensation, ability to reach orgasm,
and overall enhanced sexual experiences. A major trial finding showed that Zestra® for Women
overcame the undesirable sexual side effects associated with SSRI antidepressants such as
Paxil, Zoloft, Prozac, Celexa, Lexapro and other antidepressants in this category.
Zestra® is a proprietary blend of all natural bioactive ingredients (Borage seed oil, Evening
primrose oil, Angelica root extract, and Coleus extract) that function to increase genital sensory
nerve conduction and genital blood flow. The enhancement of genital sensory nerve conduction
by Zestra® distinguishes it from other products that simply focus on increasing blood flow to the
genitalia.
Zestra® was designed, researched and developed over six years by pharmaceutical scientists and
recognized women’s sexual health experts. The bioactive botanical ingredients in Zestr®a were
scientifically selected based on their synergistic abilities to increase female sexual sensation,
arousal and pleasure through highly specific pathways in women.
Consumers should be aware that other topical products on the market for women utilize “known
chemical irritants” such as: menthol, peppermint oil, cinnamon oil or oil of wintergreen and the
effects they produce are merely “the result of clitoral and vaginal skin irritation”. Furthermore,
most of those products contain L-Arginine, which when applied topically, can potentially reactivate
a latent herpes virus and therefore may cause genital herpes outbreaks in women who
already have genital herpes. www.zestraforwomen.com
www.HealthNewsDigest.com
Download the PDF version.
